These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 29514980)

  • 1. Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma.
    Zhao X; Zhao L; Yang H; Li J; Min X; Yang F; Liu J; Huang G
    J Biol Chem; 2018 Apr; 293(17):6623-6634. PubMed ID: 29514980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.
    Tao T; Su Q; Xu S; Deng J; Zhou S; Zhuang Y; Huang Y; He C; He S; Peng M; Hocher B; Yang X
    J Cell Physiol; 2019 Mar; 234(3):3088-3104. PubMed ID: 30221356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
    Bai PS; Xia N; Sun H; Kong Y
    J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.
    Xu D; Wang Z; Xia Y; Shao F; Xia W; Wei Y; Li X; Qian X; Lee JH; Du L; Zheng Y; Lv G; Leu JS; Wang H; Xing D; Liang T; Hung MC; Lu Z
    Nature; 2020 Apr; 580(7804):530-535. PubMed ID: 32322062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.
    Song L; Zhang W; Chang Z; Pan Y; Zong H; Fan Q; Wang L
    Med Sci Monit; 2017 Apr; 23():1741-1750. PubMed ID: 28394882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
    Min X; Wen J; Zhao L; Wang K; Li Q; Huang G; Liu J; Zhao X
    Mol Oncol; 2018 Sep; 12(9):1480-1497. PubMed ID: 30004626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
    Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression.
    Wei L; Dai Y; Zhou Y; He Z; Yao J; Zhao L; Guo Q; Yang L
    Cell Death Dis; 2017 Jul; 8(7):e2944. PubMed ID: 28726775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKM2-TMEM33 axis regulates lipid homeostasis in cancer cells by controlling SCAP stability.
    Liu F; Ma M; Gao A; Ma F; Ma G; Liu P; Jia C; Wang Y; Donahue K; Zhang S; Ong IM; Keles S; Li L; Xu W
    EMBO J; 2021 Nov; 40(22):e108065. PubMed ID: 34487377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New links between lipid accumulation and cancer progression.
    Nickels JT
    J Biol Chem; 2018 Apr; 293(17):6635-6636. PubMed ID: 29703762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
    Wong CC; Au SL; Tse AP; Xu IM; Lai RK; Chiu DK; Wei LL; Fan DN; Tsang FH; Lo RC; Wong CM; Ng IO
    PLoS One; 2014; 9(12):e115036. PubMed ID: 25541689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipogenic SREBP-1a/c transcription factors activate expression of the iron regulator hepcidin, revealing cross-talk between lipid and iron metabolisms.
    Xiaoli AM; Song Z; Yang F
    J Biol Chem; 2019 Aug; 294(34):12743-12753. PubMed ID: 31270208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,5,3'triiodo-L-thyronine induces SREBP-1 expression by non-genomic actions in human HEP G2 cells.
    Gnoni GV; Rochira A; Leone A; Damiano F; Marsigliante S; Siculella L
    J Cell Physiol; 2012 Jun; 227(6):2388-97. PubMed ID: 21826653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
    Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
    Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.
    Liu AM; Xu Z; Shek FH; Wong KF; Lee NP; Poon RT; Chen J; Luk JM
    PLoS One; 2014; 9(1):e86872. PubMed ID: 24466275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized eicosapentaenoic acids more potently reduce LXRα-induced cellular triacylglycerol via suppression of SREBP-1c, PGC-1β and GPA than its intact form.
    Nanthirudjanar T; Furumoto H; Hirata T; Sugawara T
    Lipids Health Dis; 2013 May; 12():73. PubMed ID: 23680128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
    Chen Z; Lu X; Wang Z; Jin G; Wang Q; Chen D; Chen T; Li J; Fan J; Cong W; Gao Q; He X
    Oncotarget; 2015 Feb; 6(4):2538-48. PubMed ID: 25576919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
    Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
    Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.